Kyoungsoo Lim

KyoungSoo Lim is an accomplished professional in clinical pharmacology with extensive experience in leading translational medicine and clinical pharmacology efforts. Currently serving as VP of Translational Medicine and Clinical Pharmacology at Samsung Bioepis since July 2025, KyoungSoo Lim previously held the position of Director of Clinical Pharmacology and Pharmacometrics at AstraZeneca, where notable achievements included leading multiple early and late phase clinical programs, securing IND clearance, and supporting BLA filings. KyoungSoo Lim's background also includes significant roles as Medical Director at KCRN Research, Assistant Professor at CHA University and Seoul National University Hospital, and participation in military medical research. KyoungSoo Lim holds a PhD in Medicine, Clinical Pharmacology, and a Doctor of Medicine from Seoul National University.